Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GH LABB LLC

NPI: 1689340267 · TAMPA, FL 33634 · Clinical Medical Laboratory · NPI assigned 08/23/2021

$198K
Total Medicaid Paid
27,937
Total Claims
21,325
Beneficiaries
26
Codes Billed
2022-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGIACOBBE LANEVE, MARIA (PRESIDENT)
NPI Enumeration Date08/23/2021

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 1,733 $19K
2023 7,767 $43K
2024 18,437 $137K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 3,311 2,962 $64K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5,462 4,565 $40K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,036 2,677 $29K
80365 3,134 1,600 $14K
80363 728 679 $10K
80361 3,878 1,154 $8K
80354 1,052 943 $4K
80348 941 886 $3K
80373 881 830 $3K
80358 865 813 $3K
80324 355 323 $3K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 662 590 $3K
80346 545 502 $3K
80356 646 589 $3K
80372 775 727 $2K
80349 313 301 $1K
80353 308 278 $1K
80359 260 201 $886.81
80321 133 113 $324.36
80369 96 92 $222.75
80362 137 133 $214.20
80335 87 84 $209.45
80345 25 15 $162.60
83992 65 62 $81.00
80355 215 180 $5.65
80370 27 26 $0.00